Cargando…

An analysis of the strategic plan development processes of major public organisations funding health research in nine high-income countries worldwide

BACKGROUND: There have been claims that health research is not satisfactorily addressing healthcare challenges. A specific area of concern is the adequacy of the mechanisms used to plan investments in health research. However, the way organisations within countries devise research agendas has not be...

Descripción completa

Detalles Bibliográficos
Autores principales: Morciano, Cristina, Errico, Maria Cristina, Faralli, Carla, Minghetti, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501611/
https://www.ncbi.nlm.nih.gov/pubmed/32948215
http://dx.doi.org/10.1186/s12961-020-00620-x
_version_ 1783584062986780672
author Morciano, Cristina
Errico, Maria Cristina
Faralli, Carla
Minghetti, Luisa
author_facet Morciano, Cristina
Errico, Maria Cristina
Faralli, Carla
Minghetti, Luisa
author_sort Morciano, Cristina
collection PubMed
description BACKGROUND: There have been claims that health research is not satisfactorily addressing healthcare challenges. A specific area of concern is the adequacy of the mechanisms used to plan investments in health research. However, the way organisations within countries devise research agendas has not been systematically reviewed. This study seeks to understand the legal basis, the actors and the processes involved in setting research agendas in major public health research funding organisations. METHODS: We reviewed information relating to the formulation of strategic plans by 11 public funders in nine high-income countries worldwide. Information was collected from official websites and strategic plan documents in English, French, Italian and Spanish between January 2019 and December 2019, by means of a conceptual framework and information abstraction form. RESULTS: We found that the formulation of a strategic plan is a common and well-established practice in shaping research agendas across international settings. Most of the organisations studied are legally required to present a multi-year strategic plan. In some cases, legal provisions may set rules for actors and processes and may establish areas of research and/or types of research to be funded. Commonly, the decision-making process involves both internal and external stakeholders, with the latter being generally government officials and experts, and few examples of the participation of civil society. The process also varies across organisations depending on whether there is a formal requirement to align to strategic priorities developed by an overarching entity at national level. We also found that, while actors and their interactions were traceable, information, sources of information, criteria and the mechanisms/tools used to shape decisions were made less explicit. CONCLUSIONS: A complex picture emerges in which multiple interactive entities appear to shape research plans. Given the complexity of the influences of different parties and factors, the governance of the health research sector would benefit from a traceable and standardised knowledge-based process of health research strategic planning. This would provide an opportunity to demonstrate responsible budget stewardship and, more importantly, to make efforts to remain responsive to healthcare challenges, research gaps and opportunities.
format Online
Article
Text
id pubmed-7501611
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75016112020-09-22 An analysis of the strategic plan development processes of major public organisations funding health research in nine high-income countries worldwide Morciano, Cristina Errico, Maria Cristina Faralli, Carla Minghetti, Luisa Health Res Policy Syst Research BACKGROUND: There have been claims that health research is not satisfactorily addressing healthcare challenges. A specific area of concern is the adequacy of the mechanisms used to plan investments in health research. However, the way organisations within countries devise research agendas has not been systematically reviewed. This study seeks to understand the legal basis, the actors and the processes involved in setting research agendas in major public health research funding organisations. METHODS: We reviewed information relating to the formulation of strategic plans by 11 public funders in nine high-income countries worldwide. Information was collected from official websites and strategic plan documents in English, French, Italian and Spanish between January 2019 and December 2019, by means of a conceptual framework and information abstraction form. RESULTS: We found that the formulation of a strategic plan is a common and well-established practice in shaping research agendas across international settings. Most of the organisations studied are legally required to present a multi-year strategic plan. In some cases, legal provisions may set rules for actors and processes and may establish areas of research and/or types of research to be funded. Commonly, the decision-making process involves both internal and external stakeholders, with the latter being generally government officials and experts, and few examples of the participation of civil society. The process also varies across organisations depending on whether there is a formal requirement to align to strategic priorities developed by an overarching entity at national level. We also found that, while actors and their interactions were traceable, information, sources of information, criteria and the mechanisms/tools used to shape decisions were made less explicit. CONCLUSIONS: A complex picture emerges in which multiple interactive entities appear to shape research plans. Given the complexity of the influences of different parties and factors, the governance of the health research sector would benefit from a traceable and standardised knowledge-based process of health research strategic planning. This would provide an opportunity to demonstrate responsible budget stewardship and, more importantly, to make efforts to remain responsive to healthcare challenges, research gaps and opportunities. BioMed Central 2020-09-18 /pmc/articles/PMC7501611/ /pubmed/32948215 http://dx.doi.org/10.1186/s12961-020-00620-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Morciano, Cristina
Errico, Maria Cristina
Faralli, Carla
Minghetti, Luisa
An analysis of the strategic plan development processes of major public organisations funding health research in nine high-income countries worldwide
title An analysis of the strategic plan development processes of major public organisations funding health research in nine high-income countries worldwide
title_full An analysis of the strategic plan development processes of major public organisations funding health research in nine high-income countries worldwide
title_fullStr An analysis of the strategic plan development processes of major public organisations funding health research in nine high-income countries worldwide
title_full_unstemmed An analysis of the strategic plan development processes of major public organisations funding health research in nine high-income countries worldwide
title_short An analysis of the strategic plan development processes of major public organisations funding health research in nine high-income countries worldwide
title_sort analysis of the strategic plan development processes of major public organisations funding health research in nine high-income countries worldwide
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501611/
https://www.ncbi.nlm.nih.gov/pubmed/32948215
http://dx.doi.org/10.1186/s12961-020-00620-x
work_keys_str_mv AT morcianocristina ananalysisofthestrategicplandevelopmentprocessesofmajorpublicorganisationsfundinghealthresearchinninehighincomecountriesworldwide
AT erricomariacristina ananalysisofthestrategicplandevelopmentprocessesofmajorpublicorganisationsfundinghealthresearchinninehighincomecountriesworldwide
AT farallicarla ananalysisofthestrategicplandevelopmentprocessesofmajorpublicorganisationsfundinghealthresearchinninehighincomecountriesworldwide
AT minghettiluisa ananalysisofthestrategicplandevelopmentprocessesofmajorpublicorganisationsfundinghealthresearchinninehighincomecountriesworldwide
AT morcianocristina analysisofthestrategicplandevelopmentprocessesofmajorpublicorganisationsfundinghealthresearchinninehighincomecountriesworldwide
AT erricomariacristina analysisofthestrategicplandevelopmentprocessesofmajorpublicorganisationsfundinghealthresearchinninehighincomecountriesworldwide
AT farallicarla analysisofthestrategicplandevelopmentprocessesofmajorpublicorganisationsfundinghealthresearchinninehighincomecountriesworldwide
AT minghettiluisa analysisofthestrategicplandevelopmentprocessesofmajorpublicorganisationsfundinghealthresearchinninehighincomecountriesworldwide